Louis Kayitalire

2020

In 2020, Louis Kayitalire earned a total compensation of $1M as Chief Medical Officer at F-star Therapeutics, a 39% increase compared to previous year.

Compensation breakdown

Bonus$246,250
Salary$450,000
Stock Awards$310,200
Other$20,645
Total$1,027,095

Kayitalire received $450K in salary, accounting for 44% of the total pay in 2020.

Kayitalire also received $246.3K in bonus, $310.2K in stock awards and $20.6K in other compensation.

Rankings

In 2020, Louis Kayitalire's compensation ranked 8,525th out of 13,090 executives tracked by ExecPay. In other words, Kayitalire earned more than 34.9% of executives.

ClassificationRankingPercentile
All
8,525
out of 13,090
35th
Division
Manufacturing
3,625
out of 5,621
36th
Major group
Chemicals And Allied Products
1,466
out of 2,254
35th
Industry group
Drugs
1,277
out of 1,954
35th
Industry
Pharmaceutical Preparations
943
out of 1,459
35th
Source: SEC filing on April 7, 2021.

Kayitalire's colleagues

We found seven more compensation records of executives who worked with Louis Kayitalire at F-star Therapeutics in 2020.

2020

Eliot Forster

F-star Therapeutics

Chief Executive Officer

2020

Neil Brewis

F-star Therapeutics

Chief Scientific Officer

2020

Neil DSc

F-star Therapeutics

Chief Scientific Officer

2020

Darlene Deptula-Hicks

F-star Therapeutics

Chief Financial Officer

2020

RP Iyer

F-star Therapeutics

Chief Scientific Officer

2020

Martin Driscoll

F-star Therapeutics

Chief Executive Officer

2020

Jonathan Freve

F-star Therapeutics

Chief Financial Officer

News

You may also like